Company · CIK 0001377121 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Protagonist Therapeutics, Inc · PTGX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 SForm 4 → | Sep 10, 9:17 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 125,000 | $145.92 | $18,240,568 | 522,968 | −19.3% | 10b5-1 |
| Sep 8, 2026 MForm 4 → | Sep 10, 9:17 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 125,000 | $21.58 | $2,697,500 | 530,246 | — | 10b5-1 |
| Sep 3, 2026 GForm 4 → | Sep 8, 5:14 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 510 | — | — | 522,968 | — | |
| Aug 10, 2026 SForm 4 → | Aug 12, 6:43 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 100,000 | $148.91 | $14,890,799 | 523,478 | −16.0% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 6:43 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 100,000 | $21.58 | $2,158,000 | 557,717 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 MForm 4 → | Sep 10, 9:17 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 125,000 | — | — | 0 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 6:43 pm EDT | Dinesh V Ph D PatelPresident and CEO, Director | 100,000 | — | — | 125,000 | — | 10b5-1 |